A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer’s disease and Parkinson’s disease
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
McGhee, David J. M.
Ritchie, Craig W.
Zajicek, John P.
Counsell, Carl E.
Funding for this research was provided by:
National Institute for Health Research (RP-PG-0707-10124)